| 王稳1 苟志平2△.急性缺血心肌炎症与再灌注[J].,2012,12(19):3781-3783 |
| 急性缺血心肌炎症与再灌注 |
| 急性缺血心肌炎症与再灌注 |
| |
| DOI： |
| 中文关键词: 炎症 冠心病 再灌注 急性冠脉综合症 不稳定斑块 |
| 英文关键词: Inflammation Coronary heart disease Reperfusion Acute coronary syndrom Unstable plaque |
| 基金项目: |
|
| 摘要点击次数: 707 |
| 全文下载次数: 831 |
| 中文摘要: |
| 近20 年来，随着经皮冠状动脉介入（percutaneous coronary intervention，PCI）治疗的发展，相关的研究日益增多，许多研究显
示炎症反应在行PCI 治疗的患者的预后中发挥着很大的作用。PCI 术后患者心肌再灌注的疗效日益引起人们的关注,尤其是再灌
注无复流的危害和重要性，如何控制炎症因子（如hs-CRP,IL-6,TNF-α 等）的水平，以有益于行PCI 术的患者，需要更多一些前瞻
性研究去观察。 |
| 英文摘要: |
| In recent 20 years, with the development of percutaneous coronary intervention treatment, the researches related to
PCI are increasing. Many studies have shown that inflammation plays an important role in the prognosis of the patients who accepted the
PCI treatment. The efficacy of myocardial reperfusion in these patients has attracted much attention, especially the damage and importance
of the no-reflow reperfusion. How to control the levels of inflammatory factors (such as hs-CRP, IL-6, TNF-α, etc), to benefits patients
undergoing PCI treatment, needs more prospective studies to observe. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
